Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
ProteoNic unveils Early Access Program: Elevating viral vector titers with transformative LV-2G UNic technology
, /in E-News /by panglobalProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, has launched its highly anticipated LV-2G UNic Early Access Program. This programme marks a significant milestone in lentivirus manufacturing optimization, offering access to groundbreaking vector technology designed to revolutionize viral vector production.
Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink Target Platform
, /in E-News /by panglobalSynexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, has integrated the Olink Target immunoassays and the Olink Signature Q100 instrument into its extensive suite of biomarker discovery platforms.
Could Amazon or Google hold the key to the future of public health diagnostics?
Big Four tech companies, collaboration, tricorder, universal diagnostics, /in Featured Articles /by panglobalAnyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximising the availability of self-testing and playing its part in the common goal to achieve net zero.
BBI Solutions expands IVD raw materials portfolio with IBEX Technologies acquisition
, /in E-News /by panglobalBBI Solutions OEM Limited (BBI), a leading independent manufacturer of immunodiagnostic reagents, has acquired IBEX Technologies, a leading developer and manufacturer of high-precision enzymes and diagnostic solutions located in Montréal, Canada.
ProBioGen and DIOSynVax partner to manufacture multivalent vaccine for haemorrhagic fever
, /in E-News, Hematology & Flow Cytometry /by panglobalProBioGen, a global Contract Development & Manufacturing Organization (CDMO), is partnering with DIOSynVax to manufacture DIOS-HFVac3, a trivalent haemorrhagic fever (HF) vaccine that was developed in collaboration with Prof. Dr. Ralf Wagners team at the Institute of Medical Microbiology and Hygiene, University of Regensburg. The novel vaccine targets HF diseases caused by Ebola, Marburg, and […]
Understanding the new IVD regulation and simplifying your compliance workload
, /in Featured Articles /by panglobalBy Dr Daisuke Kawakami What is the new EU In Vitro
Diasys RESPONS A1C
, /in Advertenties /by panglobalOne step HbA1c analyzer Precise and reliable HbA1c results traceable to IFCC and NGSP
Urinalysis QC Simplified.
, /in Advertenties /by panglobalQuantimetrix® puts you in control of quality with the most versatile and complete line of urinalysis quality controls, designed to meet your needs from the central lab to the point-of-care.
Euroimmun
, /in Advertenties /by panglobalUnited expertise for your allergy diagnostics
Hemostasis automation that works on so many levels.
, /in Advertenties /by panglobalHemoCell delivers workcell efficiency, quality and standardization for Hemostasis labs.